These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25392720)

  • 21. Azathioprine-induced hepatitis and cholestasis occurring 1 year after treatment.
    Chertoff J; Alam S; Black M; Elgendy IY
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25471111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three hospital admissions in 9 days to diagnose azathioprine hypersensitivity in a patient with Crohn's disease.
    Mookherjee S; Narayanan M; Uchiyama T; Wentworth KL
    Am J Ther; 2015; 22(2):e28-32. PubMed ID: 23782763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory bowel disease, azathioprine and skin cancer: case report and literature review.
    Austin AS; Spiller RC
    Eur J Gastroenterol Hepatol; 2001 Feb; 13(2):193-4. PubMed ID: 11246621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disseminated cutaneous herpes simplex infection in a patient with Crohn's disease under azathioprine and steroids: First case report and literature review.
    Santos-Antunes J; Abreu C; Magro F; Coelho R; Vilas-Boas F; Andrade P; Lopes S; Macedo G
    J Crohns Colitis; 2014 Apr; 8(4):326-30. PubMed ID: 24257435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acute azathioprine-induced pancreatitis in a female patient with Crohn's disease].
    Velicia MR; González JM; Fernández P; Remacha B; Martín MA; Sánchez G; Goyeneche ML; Caro-Paton A
    Gastroenterol Hepatol; 1999 Apr; 22(4):186-7. PubMed ID: 10349790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nodular regenerative hyperplasia as a side effect of azathioprine in a patient with Crohn's disease].
    Schumann M; Preiss JC; Loddenkemper C; Günther U; Somasundaram R; Siegmund B; Zeitz M
    Dtsch Med Wochenschr; 2008 Sep; 133(38):1897-900. PubMed ID: 18788068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases.
    Weersma RK; Peters FT; Oostenbrug LE; van den Berg AP; van Haastert M; Ploeg RJ; Posthumus MD; Homan van der Heide JJ; Jansen PL; van Dullemen HM
    Aliment Pharmacol Ther; 2004 Oct; 20(8):843-50. PubMed ID: 15479355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine.
    Dubinsky MC; Feldman EJ; Abreu MT; Targan SR; Vasiliauskas EA
    Am J Gastroenterol; 2003 May; 98(5):1058-63. PubMed ID: 12809828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver steatosis is a risk factor for hepatotoxicity in patients with inflammatory bowel disease under immunosuppressive treatment.
    Schröder T; Schmidt KJ; Olsen V; Möller S; Mackenroth T; Sina C; Lehnert H; Fellermann K; Büning J
    Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):698-704. PubMed ID: 25923946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
    Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hepatotoxicity induced by new immunosuppressants].
    Toscano E; Cotta J; Robles M; Lucena MA; Andrade RJ
    Gastroenterol Hepatol; 2010 Jan; 33(1):54-65. PubMed ID: 19889479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute diarrhea during azathioprine treatment of type I autoimmune hepatitis.
    Fracchia M; Galatola G; Pera A; Foti M; Tabone M
    Minerva Med; 2008 Apr; 99(2):219-22. PubMed ID: 18431330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute pancreatitis after azathioprine treatment for ulcerative colitis.
    Tragnone A; Bazzocchi G; Aversa G; Pecorelli MG; Elmi G; Venerato S; Lanfranchi GA
    Ital J Gastroenterol; 1996; 28(2):102-4. PubMed ID: 8782004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukopenia due to parvovirus B19 in a Crohn's disease patient using azathioprine.
    van Asseldonk DP; Kanis BM; de Boer NK; van Bodegraven AA
    Digestion; 2009; 79(4):211-4. PubMed ID: 19390192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Azathioprine induced liver disease: nodular regenerative hyperplasia of the liver and perivenous fibrosis in a patient treated for multiple sclerosis.
    Mion F; Napoleon B; Berger F; Chevallier M; Bonvoisin S; Descos L
    Gut; 1991 Jun; 32(6):715-7. PubMed ID: 2060883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.
    Kotlyar DS; Lewis JD; Beaugerie L; Tierney A; Brensinger CM; Gisbert JP; Loftus EV; Peyrin-Biroulet L; Blonski WC; Van Domselaar M; Chaparro M; Sandilya S; Bewtra M; Beigel F; Biancone L; Lichtenstein GR
    Clin Gastroenterol Hepatol; 2015 May; 13(5):847-58.e4; quiz e48-50. PubMed ID: 24879926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
    Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
    Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hodgkin's disease developing in the course of a chronic liver disease with ulcerative colitis immunosuppressed with azathioprine].
    Orbuch SJ; Findor JA
    Acta Gastroenterol Latinoam; 1979; 9(2):73-80. PubMed ID: 506643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.